Serum syndecan-1, hyaluronan and thrombomodulin levels in patients with lupus nephritis.

Like Comment
We investigated circulating syndecan-1, HA and thrombomodulin levels in patients with biopsy-proven Class III/IV ± V LN and their clinico-pathological associations. Patients with non-renal SLE or non-lupus chronic kidney disease, and healthy subjects served as controls.Serum syndecan-1, HA and thrombomodulin levels were determined by ELISAs.Syndecan-1, HA and thrombomodulin levels were significantly higher during active LN compared with remission (P 


Get PDF with LibKey


View the article @ Rheumatology (Oxford, England) (sign-in may be required)

ClinOwl

The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
2841 Contributions
1 Followers
0 Following

No comments yet.